Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Robert Berry, M.D.


Global Modification to WHO Surgical Safety Checklist
Summer, 06/17/13 - 08/16/13
WHO Surgical Safety Checklist Modification Globally: Process Checks Proliferate, Communication Components Disappear
Summer, 05/30/11 - 08/15/11

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lundy J, Gao H, Berry W, Masoumi-Moghaddam S, Jenkins BJ, Croagh D. Targeted transcriptome and KRAS mutation analysis improve the diagnostic performance of EUS-FNA biopsies in pancreatic cancer. Clin Cancer Res. 2021 Aug 16. PMID: 34400416.
    Citations:    Fields:    
  2. Aggarwal R, Plough A, Henrich N, Galvin G, Rucker A, Barnes C, Berry W, Golen T, Shah NT. The design of "TeamBirth": A care process to improve communication and teamwork during labor. Birth. 2021 Jul 09. PMID: 34245054.
    Citations:    Fields:    
  3. George DJ, Halabi S, Heath EI, Sartor AO, Sonpavde GP, Das D, Bitting RL, Berry W, Healy P, Anand M, Winters C, Riggan C, Kephart J, Wilder R, Shobe K, Rasmussen J, Milowsky MI, Fleming MT, Bearden J, Goodman M, Zhang T, Harrison MR, McNamara M, Zhang D, LaCroix BL, Kittles RA, Patierno BM, Sibley AB, Patierno SR, Owzar K, Hyslop T, Freedman JA, Armstrong AJ. A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021 Aug 15; 127(16):2954-2965. PMID: 33951180.
    Citations:    Fields:    
  4. Brown LC, Halabi S, Schonhoft JD, Yang Q, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Barnett ES, Carbone EA, Zhao JL, Healy P, Anand M, Gill A, Jendrisak A, Berry WR, Gupta S, Gregory SG, Wenstrup R, Antonarakis ES, George DJ, Scher HI, Armstrong AJ. Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide. Clin Cancer Res. 2021 Jul 15; 27(14):4077-4088. PMID: 33820782.
    Citations: 3     Fields:    
  5. Koontz BF, Hoffman KE, Halabi S, Healy P, Anand M, George DJ, Harrison MR, Zhang T, Berry WR, Corn PG, Lee WR, Armstrong AJ. Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 04 01; 109(5):1271-1278. PMID: 33259932.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  6. Armstrong AJ, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Berry WR, Zhang T, Harrison MR, Lu C, Chen Y, Galletti G, Schonhoft JD, Scher HI, Wenstrup R, Tagawa ST, Antonarakis ES, George DJ, Halabi S. Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer. JCO Precis Oncol. 2020; 4. PMID: 33154984.
    Citations: 6     
  7. Chandrakesan P, Panneerselvam J, May R, Weygant N, Qu D, Berry WR, Pitts K, Stanger BZ, Rao CV, Bronze MS, Houchen CW. DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization. Mol Cancer Ther. 2020 07; 19(7):1539-1549. PMID: 32371580.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  8. Lagoo J, Berry W, Henrich N, Gawande A, Sato L, Haas S. Safely Practicing in a New Environment: A Qualitative Study to Inform Physician Onboarding Practices. Jt Comm J Qual Patient Saf. 2020 06; 46(6):314-320. PMID: 32336617.
    Citations:    Fields:    Translation:Humans
  9. Lagoo J, Singal R, Berry W, Gawande A, Lim C, Paibulsirijit S, Havens J. Development and Feasibility Testing of a Device Briefing Tool and Training to Improve Patient Safety During Introduction of New Devices in Operating Rooms: Best Practices and Lessons Learned. J Surg Res. 2019 12; 244:579-586. PMID: 31446322.
    Citations: 1     Fields:    Translation:Humans
  10. Tucker MD, Zhu J, Marin D, Gupta RT, Gupta S, Berry WR, Ramalingam S, Zhang T, Harrison M, Wu Y, Healy P, Lisi S, George DJ, Armstrong AJ. Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer. Cancer Med. 2019 08; 8(10):4644-4655. PMID: 31270961.
    Citations: 16     Fields:    Translation:Humans
  11. Lagoo J, Berry WR, Miller K, Neal BJ, Sato L, Lillemoe KD, Doherty GM, Kasser JR, Chaikof EL, Gawande AA, Haynes AB. Multisource Evaluation of Surgeon Behavior Is Associated With Malpractice Claims. Ann Surg. 2019 07; 270(1):84-90. PMID: 29578910.
    Citations: 2     Fields:    Translation:Humans
  12. Armstrong AJ, Halabi S, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Rothwell CJ, Rasmussen J, Thornburg B, Berry WR, Wilder RS, Lu C, Chen Y, Silberstein JL, Kemeny G, Galletti G, Somarelli JA, Gupta S, Gregory SG, Scher HI, Dittamore R, Tagawa ST, Antonarakis ES, George DJ. Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study. J Clin Oncol. 2019 05 01; 37(13):1120-1129. PMID: 30865549.
    Citations: 74     Fields:    Translation:HumansCellsCTClinical Trials
  13. Petrylak DP, Kantoff P, Vogelzang NJ, Mega A, Fleming MT, Stephenson JJ, Frank R, Shore ND, Dreicer R, McClay EF, Berry WR, Agarwal M, DiPippo VA, Rotshteyn Y, Stambler N, Olson WC, Morris SA, Israel RJ. Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer. Prostate. 2019 05; 79(6):604-613. PMID: 30663074.
    Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
  14. Davis KK, Mahishi V, Singal R, Urman RD, Miller MA, Cooke M, Berry WR. Quality Improvement in Ambulatory Surgery Centers: A Major National Effort Aimed at Reducing Infections and Other Surgical Complications. J Clin Med Res. 2019 Jan; 11(1):7-14. PMID: 30627272.
  15. Berry WR, Edmondson L, Gibbons LR, Childers AK, Haynes AB, Foster R, Singer SJ, Gawande AA. Scaling Safety: The South Carolina Surgical Safety Checklist Experience. Health Aff (Millwood). 2018 11; 37(11):1779-1786. PMID: 30395507.
    Citations: 3     Fields:    Translation:Humans
  16. Solsky I, Berry W, Edmondson L, Lagoo J, Baugh J, Blair A, Singer S, Haynes AB. World Health Organization Surgical Safety Checklist Modification: Do Changes Emphasize Communication and Teamwork? J Surg Res. 2020 02; 246:614-622. PMID: 30528925.
    Citations:    Fields:    
  17. Harper AR, Le AT, Mather T, Burgett A, Berry W, Summers JA. Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes. Bioorg Med Chem. 2018 12 01; 26(22):5766-5779. PMID: 30409702.
    Citations:    Fields:    Translation:HumansAnimalsCells
  18. Cheng YW, Sandrasegaran K, Cheng K, Shah A, Ghabril M, Berry W, Lammert C, Chalasani N, Orman ES. A dedicated paracentesis clinic decreases healthcare utilization for serial paracenteses in decompensated cirrhosis. Abdom Radiol (NY). 2018 08; 43(8):2190-2197. PMID: 29188319.
    Citations: 1     Fields:    Translation:Humans
  19. Gupta S, Nordquist LT, Fleming MT, Berry WR, Zhang J, Ervin SL, Eisner JR, Baskin-Bey ES, Shore ND. Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer. Clin Cancer Res. 2018 11 01; 24(21):5225-5232. PMID: 30012563.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  20. Columbus AB, Castillo-Angeles M, Berry WR, Haider AH, Salim A, Havens JM. An evidence-based intraoperative communication tool for emergency general surgery: a pilot study. J Surg Res. 2018 08; 228:281-289. PMID: 29907223.
    Citations: 1     Fields:    Translation:Humans
  21. Brindle ME, Henrich N, Foster A, Marks S, Rose M, Welsh R, Berry W. Implementation of surgical debriefing programs in large health systems: an exploratory qualitative analysis. BMC Health Serv Res. 2018 03 27; 18(1):210. PMID: 29580254.
    Citations: 2     Fields:    Translation:Humans
  22. Alidina S, Goldhaber-Fiebert SN, Hannenberg AA, Hepner DL, Singer SJ, Neville BA, Sachetta JR, Lipsitz SR, Berry WR. Factors associated with the use of cognitive aids in operating room crises: a cross-sectional study of US hospitals and ambulatory surgical centers. Implement Sci. 2018 03 26; 13(1):50. PMID: 29580243.
    Citations: 6     Fields:    Translation:Humans
  23. Forrester JA, Koritsanszky LA, Amenu D, Haynes AB, Berry WR, Alemu S, Jiru F, Weiser TG. Developing Process Maps as a Tool for a Surgical Infection Prevention Quality Improvement Initiative in Resource-Constrained Settings. J Am Coll Surg. 2018 06; 226(6):1103-1116.e3. PMID: 29574175.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  24. Haynes AB, Edmondson L, Lipsitz SR, Molina G, Neville BA, Singer SJ, Moonan AT, Childers AK, Foster R, Gibbons LR, Gawande AA, Berry WR. Mortality Trends After a Voluntary Checklist-based Surgical Safety Collaborative. Ann Surg. 2017 12; 266(6):923-929. PMID: 29140848.
    Citations: 10     Fields:    Translation:Humans
  25. Molina G, Berry WR, Lipsitz SR, Edmondson L, Li Z, Neville BA, Moonan AT, Gibbons LR, Gawande AA, Singer SJ, Haynes AB. Perception of Safety of Surgical Practice Among Operating Room Personnel From Survey Data Is Associated With All-cause 30-day Postoperative Death Rate in South Carolina. Ann Surg. 2017 10; 266(4):658-666. PMID: 28657942.
    Citations: 4     Fields:    Translation:Humans
  26. Plough AC, Galvin G, Li Z, Lipsitz SR, Alidina S, Henrich NJ, Hirschhorn LR, Berry WR, Gawande AA, Peter D, McDonald R, Caldwell DL, Muri JH, Bingham D, Caughey AB, Declercq ER, Shah NT. Relationship Between Labor and Delivery Unit Management Practices and Maternal Outcomes. Obstet Gynecol. 2017 08; 130(2):358-365. PMID: 28697107.
    Citations: 8     Fields:    Translation:Humans
  27. Alidina S, Hur HC, Berry WR, Molina G, Guenthner G, Modest AM, Singer SJ. Narrative feedback from OR personnel about the safety of their surgical practice before and after a surgical safety checklist intervention. Int J Qual Health Care. 2017 Aug 01; 29(4):461-469. PMID: 28482011.
    Citations: 1     Fields:    Translation:Humans
  28. Hepner DL, Arriaga AF, Cooper JB, Goldhaber-Fiebert SN, Gaba DM, Berry WR, Boorman DJ, Bader AM. Operating Room Crisis Checklists and Emergency Manuals. Anesthesiology. 2017 Aug; 127(2):384-392. PMID: 28604405.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  29. Brindle ME, Roberts DJ, Daodu O, Haynes AB, Cauley C, Dixon E, La Flamme C, Bain P, Berry W. Deriving literature-based benchmarks for surgical complications in high-income countries: a protocol for a systematic review and meta-analysis. BMJ Open. 2017 05 09; 7(5):e013780. PMID: 28487456.
    Citations:    Fields:    Translation:Humans
  30. Bourne RS, Shulman R, Tomlin M, Borthwick M, Berry W, Mills GH. Reliability of clinical impact grading by healthcare professionals of common prescribing error and optimisation cases in critical care patients. Int J Qual Health Care. 2017 Apr 01; 29(2):250-255. PMID: 28453820.
    Citations: 1     Fields:    Translation:Humans
  31. Lashoher A, Schneider EB, Juillard C, Stevens K, Colantuoni E, Berry WR, Bloem C, Chadbunchachai W, Dharap S, Dy SM, Dziekan G, Gruen RL, Henry JA, Huwer C, Joshipura M, Kelley E, Krug E, Kumar V, Kyamanywa P, Mefire AC, Musafir M, Nathens AB, Ngendahayo E, Nguyen TS, Roy N, Pronovost PJ, Khan IQ, Razzak JA, Rubiano AM, Turner JA, Varghese M, Zakirova R, Mock C. Implementation of the World Health Organization Trauma Care Checklist Program in 11 Centers Across Multiple Economic Strata: Effect on Care Process Measures. World J Surg. 2017 Apr; 41(4):954-962. PMID: 27800590.
    Citations: 13     Fields:    Translation:Humans
  32. Bloom JD, Britton J, Berry W. The Oregon Court of Appeals and the State Civil Commitment Statute. J Am Acad Psychiatry Law. 2017 Mar; 45(1):52-61. PMID: 28270463.
    Citations:    Fields:    Translation:Humans
  33. Griffith J, Andrade D, Mehta M, Berry W, Benbrook DM, Aravindan N, Herman TS, Ramesh R, Munshi A. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy. Oncol Rep. 2017 Apr; 37(4):2382-2390. PMID: 28260023.
    Citations: 5     Fields:    Translation:HumansCells
  34. Berry W, Algar E, Kumar B, Desmond C, Swan M, Jenkins BJ, Croagh D. Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors. Int J Cancer. 2017 05 15; 140(10):2331-2343. PMID: 28198009.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  35. Bourne RS, Shulman R, Tomlin M, Borthwick M, Berry W, Mills GH. Reliability of clinical impact grading by healthcare professionals of common prescribing error and optimisation cases in critical care patients. Int J Qual Health Care. 2017 Jan 31; 1-6. PMID: 28158444.
  36. Vogelzang NJ, Fizazi K, Burke JM, De Wit R, Bellmunt J, Hutson TE, Crane E, Berry WR, Doner K, Hainsworth JD, Wiechno PJ, Liu K, Waldman MF, Gandhi A, Barton D, Jungnelius U, Fandi A, Sternberg CN, Petrylak DP. Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2017 02; 71(2):168-171. PMID: 27522164.
    Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
  37. Singer SJ, Molina G, Li Z, Jiang W, Nurudeen S, Kite JG, Edmondson L, Foster R, Haynes AB, Berry WR. Relationship Between Operating Room Teamwork, Contextual Factors, and Safety Checklist Performance. J Am Coll Surg. 2016 10; 223(4):568-580.e2. PMID: 27469627.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  38. Molina G, Neville BA, Lipsitz SR, Gibbons L, Childers AK, Gawande AA, Berry WR, Haynes AB. Postoperative acute care use after freestanding ambulatory surgery. J Surg Res. 2016 10; 205(2):331-340. PMID: 27664881.
    Citations: 1     Fields:    Translation:Humans
  39. Berry W, Haynes A, Lagoo J. The Surgical Checklist: It Cannot Work If You Do Not Use It. JAMA Surg. 2016 07 01; 151(7):647. PMID: 26842306.
    Citations: 2     Fields:    Translation:Humans
  40. Wong JM, Perry WRG, Greenberg Y, Ho AL, Lipsitz SR, Goumnerova LC, Laws ER, Berry WR, Gawande AA, Bader AM. Integrating Cerebrospinal Fluid Shunt Quality Checks into the World Health Organization's Safe Surgery Checklist: A Pilot Study. World Neurosurg. 2016 Aug; 92:491-498.e3. PMID: 27350301.
    Citations:    Fields:    
  41. Smith MR, Antonarakis ES, Ryan CJ, Berry WR, Shore ND, Liu G, Alumkal JJ, Higano CS, Chow Maneval E, Bandekar R, de Boer CJ, Yu MK, Rathkopf DE. Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort. Eur Urol. 2016 12; 70(6):963-970. PMID: 27160947.
    Citations: 33     Fields:    Translation:HumansCTClinical Trials
  42. Sandrasegaran K, Thayalan N, Thavanesan R, Kohli M, Berry W, Shah A, Kwo P. Risk factors for bleeding after liver biopsy. Abdom Radiol (NY). 2016 04; 41(4):643-9. PMID: 26847020.
    Citations: 4     Fields:    Translation:Humans
  43. Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, Fu R, Azad T, Chao TE, Berry WR, Gawande AA. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ. 2016 Mar 01; 94(3):201-209F. PMID: 26966331.
    Citations: 88     Fields:    Translation:Humans
  44. Molina G, Jiang W, Edmondson L, Gibbons L, Huang LC, Kiang MV, Haynes AB, Gawande AA, Berry WR, Singer SJ. Implementation of the Surgical Safety Checklist in South Carolina Hospitals Is Associated with Improvement in Perceived Perioperative Safety. J Am Coll Surg. 2016 05; 222(5):725-736.e5. PMID: 27049781.
    Citations: 8     Fields:    Translation:Humans
  45. Molina G, Weiser TG, Lipsitz SR, Esquivel MM, Uribe-Leitz T, Azad T, Shah N, Semrau K, Berry WR, Gawande AA, Haynes AB. Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality. JAMA. 2015 Dec 01; 314(21):2263-70. PMID: 26624825.
    Citations: 109     Fields:    Translation:Humans
  46. Dickie H, Tovey L, Berry W, Ostermann M. Revised algorithm for heparin anticoagulation during continuous renal replacement therapy. Crit Care. 2015 Oct 27; 19:376. PMID: 26502904.
    Citations: 1     Fields:    Translation:Humans
  47. Nurudeen SM, Kwakye G, Berry WR, Chaikof EL, Lillemoe KD, Millham F, Rubin M, Schwaitzberg S, Shamberger RC, Zinner MJ, Sato L, Lipsitz S, Gawande AA, Haynes AB. Can 360-Degree Reviews Help Surgeons? Evaluation of Multisource Feedback for Surgeons in a Multi-Institutional Quality Improvement Project. J Am Coll Surg. 2015 Oct; 221(4):837-44. PMID: 26272014.
    Citations: 8     Fields:    Translation:Humans
  48. Kim RY, Kwakye G, Kwok AC, Baltaga R, Ciobanu G, Merry AF, Funk LM, Lipsitz SR, Gawande AA, Berry WR, Haynes AB. Sustainability and long-term effectiveness of the WHO surgical safety checklist combined with pulse oximetry in a resource-limited setting: two-year update from Moldova. JAMA Surg. 2015 May; 150(5):473-9. PMID: 25806951.
    Citations: 7     Fields:    Translation:Humans
  49. Haynes AB, Berry WR, Gawande AA. What do we know about the safe surgery checklist now? Ann Surg. 2015 May; 261(5):829-30. PMID: 25647061.
    Citations: 9     Fields:    Translation:Humans
  50. Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, Fu R, Azad T, Chao TE, Berry WR, Gawande AA. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015 Apr 27; 385 Suppl 2:S11. PMID: 26313057.
    Citations: 113     Fields:    
  51. Molina G, Esquivel MM, Uribe-Leitz T, Lipsitz SR, Azad T, Shah N, Semrau K, Berry WR, Gwande AA, Weiser TG, Haynes AB. Avoidable maternal and neonatal deaths associated with improving access to caesarean delivery in countries with low caesarean delivery rates: an ecological modelling analysis. Lancet. 2015 Apr 27; 385 Suppl 2:S33. PMID: 26313081.
    Citations: 5     Fields:    
  52. Singer SJ, Jiang W, Huang LC, Gibbons L, Kiang MV, Edmondson L, Gawande AA, Berry WR. Surgical team member assessment of the safety of surgery practice in 38 South Carolina hospitals. Med Care Res Rev. 2015 Jun; 72(3):298-323. PMID: 25828528.
    Citations: 4     Fields:    Translation:Humans
  53. Joshua AM, Shore ND, Saad F, Chi KN, Olsson CA, Emmenegger U, Scholz M, Berry W, Mukherjee SD, Winquist E, Haas NB, Foley MA, Dmuchowski C, Perabo F, Hirmand M, Hasabou N, Rathkopf D. Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America. Prostate. 2015 Jun; 75(8):836-44. PMID: 25683285.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  54. McNamara M, Berry W. Complete Biochemical Response (Prostate Specific Antigen) to Sipuleucel-T in Metastatic Castrate-Resistant Prostate Cancer: A Case Report With Docetaxel Chemotherapy Administered Just Before Sipuleucel-T. Clin Genitourin Cancer. 2015 Oct; 13(5):e361-4. PMID: 25735199.
    Citations: 1     Fields:    Translation:Humans
  55. Haynes AB, Berry WR, Gawande AA. Surgical safety checklists in ontario, Canada. N Engl J Med. 2014 06 12; 370(24):2350. PMID: 24918389.
    Citations: 2     Fields:    Translation:Humans
  56. Arriaga AF, Gawande AA, Raemer DB, Jones DB, Smink DS, Weinstock P, Dwyer K, Lipsitz SR, Peyre S, Pawlowski JB, Muret-Wagstaff S, Gee D, Gordon JA, Cooper JB, Berry WR. Pilot testing of a model for insurer-driven, large-scale multicenter simulation training for operating room teams. Ann Surg. 2014 Mar; 259(3):403-10. PMID: 24263327.
    Citations: 9     Fields:    Translation:Humans
  57. McCrum ML, Lipsitz SR, Berry WR, Jha AK, Gawande AA. Beyond volume: does hospital complexity matter?: an analysis of inpatient surgical mortality in the United States. Med Care. 2014 Mar; 52(3):235-42. PMID: 24509361.
    Citations: 11     Fields:    Translation:Humans
  58. Huang LC, Conley D, Lipsitz S, Wright CC, Diller TW, Edmondson L, Berry WR, Singer SJ. The Surgical Safety Checklist and Teamwork Coaching Tools: a study of inter-rater reliability. BMJ Qual Saf. 2014 Aug; 23(8):639-50. PMID: 24497526.
    Citations: 2     Fields:    Translation:Humans
  59. Duclos A, Polazzi S, Lipsitz SR, Couray-Targe S, Gawande AA, Colin C, Berry W, Ayanian JZ, Carty MJ. Temporal variation in surgical mortality within French hospitals. Med Care. 2013 Dec; 51(12):1085-93. PMID: 24231784.
    Citations: 6     Fields:    Translation:Humans
  60. Funk LM, Conley DM, Berry WR, Gawande AA. Hospital management practices and availability of surgery in sub-Saharan Africa: a pilot study of three hospitals. World J Surg. 2013 Nov; 37(11):2520-8. PMID: 23942530.
    Citations: 2     Fields:    Translation:Humans
  61. Taplin ME, Berry WR, Casey AM, Aslo A. A urologic oncology roundtable discussion: issues to consider in choosing treatment for metastatic castration-resistant prostate cancer. Hosp Pract (1995). 2013 Oct-Nov; 41(4):81-2. PMID: 24145593.
    Citations:    Fields:    Translation:Humans
  62. Spector JM, Lashoher A, Agrawal P, Lemer C, Dziekan G, Bahl R, Mathai M, Merialdi M, Berry W, Gawande AA. Designing the WHO Safe Childbirth Checklist program to improve quality of care at childbirth. Int J Gynaecol Obstet. 2013 Aug; 122(2):164-8. PMID: 23742897.
    Citations: 29     Fields:    Translation:Humans
  63. Bowman KG, Jovic G, Rangel S, Berry WR, Gawande AA. Pediatric emergency and essential surgical care in Zambian hospitals: a nationwide study. J Pediatr Surg. 2013 Jun; 48(6):1363-70. PMID: 23845631.
    Citations: 9     Fields:    Translation:Humans
  64. Eappen S, Lane BH, Rosenberg B, Lipsitz SA, Sadoff D, Matheson D, Berry WR, Lester M, Gawande AA. Relationship between occurrence of surgical complications and hospital finances. JAMA. 2013 Apr 17; 309(15):1599-606. PMID: 23592104.
    Citations: 45     Fields:    Translation:Humans
  65. Kwok AC, Funk LM, Baltaga R, Lipsitz SR, Merry AF, Dziekan G, Ciobanu G, Berry WR, Gawande AA. Implementation of the World Health Organization surgical safety checklist, including introduction of pulse oximetry, in a resource-limited setting. Ann Surg. 2013 Apr; 257(4):633-9. PMID: 23207242.
    Citations: 30     Fields:    Translation:Humans
  66. Huang L, Kim R, Berry W. Creating a culture of safety by using checklists. AORN J. 2013 Mar; 97(3):365-8. PMID: 23452700.
    Citations: 1     Fields:    
  67. Bhor M, Vogelzang NJ, Hennessy D, Nicacio LV, Berry WR, Hutson TE, Fleming MT, Cowey CL, Saravanan S, Dhanda R, Sonpavde G. Sequencing of cabazitaxel and abiraterone acetate following docetaxel in metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol. 2013 Feb 20; 31(6_suppl):79. PMID: 28137106.
  68. Cooperberg MR, Vogelzang NJ, Scholz MC, Concepcion RS, Berry WR, Pieczonka C, Dakhil SR, Vacirca JL, Sandler A, McCoy C, Whitmore JB, Tyler RC, Higano CS. Real-world experience with sipuleucel-T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who received prior docetaxel (D): Data from PROCEED. J Clin Oncol. 2013 Feb 20; 31(6_suppl):30. PMID: 28136973.
  69. Sartor AO, Cooperberg MR, Vacirca JL, Concepcion RS, Berry WR, Dhawan M, Tutrone R, Sandler A, McCoy C, Whitmore JB, Tyler RC, Higano CS. Real-world experience with sipuleucel-T in patients (pts) =80 years old with metastatic castration-resistant prostate cancer (mCRPC): Data from PROCEED. J Clin Oncol. 2013 Feb 20; 31(6_suppl):131. PMID: 28136915.
  70. Antonarakis ES, Ryan CJ, Berry WR, Shore N, Liu G, Alumkal JJ, Higano CS, Maneval EC, Rathkopf DE. ARN-509 in men with high-risk nonmetastatic castration-resistant prostate cancer (CRPC). J Clin Oncol. 2013 Feb 20; 31(6_suppl):7. PMID: 28137160.
  71. Arriaga AF, Bader AM, Wong JM, Lipsitz SR, Berry WR, Ziewacz JE, Hepner DL, Boorman DJ, Pozner CN, Smink DS, Gawande AA. Simulation-based trial of surgical-crisis checklists. N Engl J Med. 2013 Jan 17; 368(3):246-53. PMID: 23323901.
    Citations: 88     Fields:    Translation:Humans
  72. Weiser TG, Berry WR. Review article: perioperative checklist methodologies. Can J Anaesth. 2013 Feb; 60(2):136-42. PMID: 23233394.
    Citations: 7     Fields:    Translation:Humans
  73. Pond GR, Berry WR, Galsky MD, Wood BA, Leopold L, Sonpavde G. Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer. Clin Genitourin Cancer. 2012 Dec; 10(4):239-45. PMID: 23000202.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  74. Berry WR. Cardiac resuscitation in the operating room: reflections on how we can do better. Can J Anaesth. 2012 Jun; 59(6):522-6. PMID: 22538859.
    Citations: 2     Fields:    Translation:Humans
  75. Stevens LM, Cooper JB, Raemer DB, Schneider RC, Frankel AS, Berry WR, Agnihotri AK. Educational program in crisis management for cardiac surgery teams including high realism simulation. J Thorac Cardiovasc Surg. 2012 Jul; 144(1):17-24. PMID: 22502966.
    Citations: 7     Fields:    Translation:Humans
  76. Fleming MT, Sonpavde G, Kolodziej M, Awasthi S, Hutson TE, Martincic D, Rastogi A, Rousey SR, Weinstein RE, Galsky MD, Berry WR, Wang Y, Boehm KA, Asmar L, Rauch MA, Beer TM. Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer. Clin Genitourin Cancer. 2012 Mar; 10(1):6-14. PMID: 22340631.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  77. Pond GR, Berry WR, Galsky MD, Wood BA, Leopold LH, Sonpavde G. Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol. 2012 Feb 10; 30(5_suppl):51. PMID: 28142927.
  78. Weiser TG, Semel ME, Simon AE, Lipsitz SR, Haynes AB, Funk LM, Berry WR, Gawande AA. In-hospital death following inpatient surgical procedures in the United States, 1996-2006. World J Surg. 2011 Sep; 35(9):1950-6. PMID: 21732207.
    Citations: 8     Fields:    Translation:Humans
  79. Pond GR, Armstrong AJ, Wood BA, Brookes M, Leopold L, Berry WR, de Wit R, Eisenberger MA, Tannock IF, Sonpavde G. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol. 2012 Feb; 61(2):363-9. PMID: 21715086.
    Citations: 7     Fields:    Translation:Humans
  80. Ziewacz JE, Arriaga AF, Bader AM, Berry WR, Edmondson L, Wong JM, Lipsitz SR, Hepner DL, Peyre S, Nelson S, Boorman DJ, Smink DS, Ashley SW, Gawande AA. Crisis checklists for the operating room: development and pilot testing. J Am Coll Surg. 2011 Aug; 213(2):212-217.e10. PMID: 21658974.
    Citations: 35     Fields:    Translation:HumansPHPublic Health
  81. Arriaga AF, Elbardissi AW, Regenbogen SE, Greenberg CC, Berry WR, Lipsitz S, Moorman D, Kasser J, Warshaw AL, Zinner MJ, Gawande AA. A policy-based intervention for the reduction of communication breakdowns in inpatient surgical care: results from a Harvard surgical safety collaborative. Ann Surg. 2011 May; 253(5):849-54. PMID: 21173696.
    Citations: 8     Fields:    Translation:Humans
  82. Funk LM, Gawande AA, Semel ME, Lipsitz SR, Berry WR, Zinner MJ, Jha AK. Esophagectomy outcomes at low-volume hospitals: the association between systems characteristics and mortality. Ann Surg. 2011 May; 253(5):912-7. PMID: 21422913.
    Citations: 22     Fields:    Translation:Humans
  83. Scher HI, Jia X, Chi K, de Wit R, Berry WR, Albers P, Henick B, Waterhouse D, Ruether DJ, Rosen PJ, Meluch AA, Nordquist LT, Venner PM, Heidenreich A, Chu L, Heller G. Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. J Clin Oncol. 2011 Jun 01; 29(16):2191-8. PMID: 21483004.
    Citations: 71     Fields:    Translation:HumansCTClinical Trials
  84. Conley DM, Singer SJ, Edmondson L, Berry WR, Gawande AA. Effective surgical safety checklist implementation. J Am Coll Surg. 2011 May; 212(5):873-9. PMID: 21398154.
    Citations: 70     Fields:    Translation:Humans
  85. Sonpavde G, Pond GR, Berry WR, de Wit R, Eisenberger MA, Tannock IF, Armstrong AJ. The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy. Cancer. 2011 Sep 01; 117(17):3963-71. PMID: 21365623.
    Citations: 7     Fields:    Translation:Humans
  86. Haynes AB, Regenbogen SE, Weiser TG, Lipsitz SR, Dziekan G, Berry WR, Gawande AA. Surgical outcome measurement for a global patient population: validation of the Surgical Apgar Score in 8 countries. Surgery. 2011 Apr; 149(4):519-24. PMID: 21216419.
    Citations: 26     Fields:    Translation:Humans
  87. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, Dziekan G, Herbosa T, Kibatala PL, Lapitan MC, Merry AF, Reznick RK, Taylor B, Vats A, Gawande AA. Changes in safety attitude and relationship to decreased postoperative morbidity and mortality following implementation of a checklist-based surgical safety intervention. BMJ Qual Saf. 2011 Jan; 20(1):102-7. PMID: 21228082.
    Citations: 79     Fields:    Translation:Humans
  88. Sonpavde G, Pond GR, Berry WR, de Wit R, Armstrong AJ, Eisenberger MA, Tannock IF. Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy. Urol Oncol. 2012 Sep; 30(5):607-13. PMID: 20888271.
    Citations: 37     Fields:    Translation:Humans
  89. Semel ME, Resch S, Haynes AB, Funk LM, Bader A, Berry WR, Weiser TG, Gawande AA. Adopting a surgical safety checklist could save money and improve the quality of care in U.S. hospitals. Health Aff (Millwood). 2010 Sep; 29(9):1593-9. PMID: 20820013.
    Citations: 29     Fields:    Translation:Humans
  90. Weiser TG, Haynes AB, Lashoher A, Dziekan G, Boorman DJ, Berry WR, Gawande AA. Perspectives in quality: designing the WHO Surgical Safety Checklist. Int J Qual Health Care. 2010 Oct; 22(5):365-70. PMID: 20702569.
    Citations: 36     Fields:    Translation:Humans
  91. Funk LM, Weiser TG, Berry WR, Lipsitz SR, Merry AF, Enright AC, Wilson IH, Dziekan G, Gawande AA. Global operating theatre distribution and pulse oximetry supply: an estimation from reported data. Lancet. 2010 Sep 25; 376(9746):1055-61. PMID: 20598365.
    Citations: 76     Fields:    Translation:Humans
  92. Weiser TG, Haynes AB, Dziekan G, Berry WR, Lipsitz SR, Gawande AA. Effect of a 19-item surgical safety checklist during urgent operations in a global patient population. Ann Surg. 2010 May; 251(5):976-80. PMID: 20395848.
    Citations: 69     Fields:    Translation:Humans
  93. Sonpavde G, Aparicio AM, Zhan F, North B, Delaune R, Garbo LE, Rousey SR, Weinstein RE, Xiao L, Boehm KA, Asmar L, Fleming MT, Galsky MD, Berry WR, Von Hoff DD. Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer. Urol Oncol. 2011 Nov-Dec; 29(6):682-9. PMID: 19959380.
    Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
  94. ElBardissi AW, Regenbogen SE, Greenberg CC, Berry W, Arriaga A, Moorman D, Retik A, Warshaw AL, Zinner MJ, Gawande AA. Communication practices on 4 Harvard surgical services: a surgical safety collaborative. Ann Surg. 2009 Dec; 250(6):861-5. PMID: 19855264.
    Citations: 5     Fields:    Translation:Humans
  95. Abbett SK, Yokoe DS, Lipsitz SR, Bader AM, Berry WR, Tamplin EM, Gawande AA. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009 Nov; 30(11):1062-9. PMID: 19751156.
    Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
  96. Sternberg CN, Petrylak DP, Sartor O, Witjes JA, Demkow T, Ferrero JM, Eymard JC, Falcon S, Calabrò F, James N, Bodrogi I, Harper P, Wirth M, Berry W, Petrone ME, McKearn TJ, Noursalehi M, George M, Rozencweig M. Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. J Clin Oncol. 2009 Nov 10; 27(32):5431-8. PMID: 19805692.
    Citations: 96     Fields:    Translation:HumansCTClinical Trials
  97. Arriaga AF, Lancaster RT, Berry WR, Regenbogen SE, Lipsitz SR, Kaafarani HM, Elbardissi AW, Desai P, Ferzoco SJ, Bleday R, Breen E, Kastrinakis WV, Rubin MS, Gawande AA. The better colectomy project: association of evidence-based best-practice adherence rates to outcomes in colorectal surgery. Ann Surg. 2009 Oct; 250(4):507-13. PMID: 19734778.
    Citations: 17     Fields:    Translation:Humans
  98. Weiser TG, Makary MA, Haynes AB, Dziekan G, Berry WR, Gawande AA. Standardised metrics for global surgical surveillance. Lancet. 2009 Sep 26; 374(9695):1113-7. PMID: 19782877.
    Citations: 45     Fields:    Translation:Humans
  99. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, Herbosa T, Joseph S, Kibatala PL, Lapitan MC, Merry AF, Moorthy K, Reznick RK, Taylor B, Gawande AA. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009 Jan 29; 360(5):491-9. PMID: 19144931.
    Citations: 810     Fields:    Translation:Humans
  100. Sonpavde G, Hutson TE, Berry WR, Boehm KA, Asmar L. Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy. Clin Genitourin Cancer. 2008 Sep; 6(2):134-7. PMID: 18824440.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  101. Coughlin RR, Kelly NA, Berry W. Nongovernmental organizations in musculoskeletal care: Orthopaedics Overseas. Clin Orthop Relat Res. 2008 Oct; 466(10):2438-42. PMID: 18685907.
    Citations: 6     Fields:    Translation:Humans
  102. Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008 Jul 12; 372(9633):139-44. PMID: 18582931.
    Citations: 547     Fields:    Translation:HumansPHPublic Health
  103. Hutson TE, Vukelja S, Atienza D, Awasthi S, Delaune R, Deutsch M, Dien PY, Gregory TF, Kolodziej MJ, Muscato JJ, Raju RN, Ruxer RL, Mull S, Ilegbodu D, Hood K, Nicol S, Berry W. Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium. Invest New Drugs. 2008 Apr; 26(2):151-8. PMID: 18236006.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  104. Sonpavde G, Chi KN, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Berry WR, Kadmon D. Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer. Cancer. 2007 Dec 15; 110(12):2628-39. PMID: 17941029.
    Citations: 9     Fields:    Translation:Humans
  105. Sonpavde G, Aparicio A, Guttierez I, Boehm KA, Hutson TE, Berry WR, Asmar L, von Hoff DD. Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy. Clin Genitourin Cancer. 2007 Dec; 5(7):457-9. PMID: 18272030.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  106. Fizazi K, Le Maitre A, Hudes G, Berry WR, Kelly WK, Eymard JC, Logothetis CJ, Pignon JP, Michiels S. Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data. Lancet Oncol. 2007 Nov; 8(11):994-1000. PMID: 17942366.
    Citations: 14     Fields:    Translation:Humans
  107. Berry W. I'm a surgeon, not a teammate. J Med Pract Manage. 2007 Mar-Apr; 22(5):307-9. PMID: 17494492.
    Citations:    Fields:    Translation:Humans
  108. Berry W, Elkordy M, O'Rourke M, Khan M, Asmar L. Results of a phase II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based clinic? Cancer Invest. 2007 Feb; 25(1):27-31. PMID: 17364554.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  109. Chittoor S, Berry W, Loesch D, Logie K, Fleagle J, Mull S, Boehm KA, Zhan F, Asmar L. Phase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer. Clin Genitourin Cancer. 2006 Dec; 5(3):212-8. PMID: 17239275.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  110. Sonpavde G, Hutson TE, Galsky MD, Berry WR. Problems with the randomized discontinuation design. J Clin Oncol. 2006 Oct 01; 24(28):4669-70; author reply 4670-1. PMID: 17008711.
    Citations: 1     Fields:    Translation:Humans
  111. Berry W, Friedland D, Fleagle J, Jackson D, Ilegbodu D, Boehm KA, Asmar L. A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer. Clin Genitourin Cancer. 2006 Sep; 5(2):131-7. PMID: 17026801.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  112. Berry W. Surgical malpractice: myths and realities. J Med Pract Manage. 2006 Jul-Aug; 22(1):50-1. PMID: 16986643.
    Citations: 1     Fields:    Translation:Humans
  113. Sonpavde G, Hutson TE, Berry WR. Systemic chemotherapy for urothelial cancer. Clin Genitourin Cancer. 2006 Jun; 5(1):34-42. PMID: 16859577.
    Citations: 1     Fields:    Translation:Humans
  114. Berry WR. Systemic therapy for prostate cancer. N C Med J. 2006 Mar-Apr; 67(2):154-7. PMID: 16752722.
    Citations:    Fields:    Translation:Humans
  115. Sonpavde G, Hutson TE, Berry WR. Hormone refractory prostate cancer: Management and advances. Cancer Treat Rev. 2006 Apr; 32(2):90-100. PMID: 16458434.
    Citations: 6     Fields:    Translation:Humans
  116. Berry WR. The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer. Urology. 2005 Jun; 65(6 Suppl):2-7. PMID: 15939076.
    Citations: 8     Fields:    Translation:Humans
  117. Berry WR. Re-induction of hormonal sensitivity in hormone-refractory prostate cancer--fact or fiction? Nat Clin Pract Oncol. 2005 Apr; 2(4):180-1. PMID: 16264926.
    Citations:    Fields:    Translation:Humans
  118. Berry W, Eisenberger M. Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy. Oncologist. 2005; 10 Suppl 3:30-9. PMID: 16368869.
    Citations: 9     Fields:    Translation:Humans
  119. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004 Oct 07; 351(15):1502-12. PMID: 15470213.
    Citations: 1610     Fields:    Translation:HumansCTClinical Trials
  120. Berry WR, Hathorn JW, Dakhil SR, Loesch DM, Jackson DV, Gregurich MA, Newcomb-Fernandez JK, Asmar L. Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer. Clin Prostate Cancer. 2004 Sep; 3(2):104-11. PMID: 15479494.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  121. Beer TM, Berry W, Wersinger EM, Bland LB. Weekly docetaxel in elderly patients with prostate cancer: efficacy and toxicity in patients at least 70 years of age compared with patients younger than 70 years. Clin Prostate Cancer. 2003 Dec; 2(3):167-72. PMID: 15040860.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  122. Gregory SA, Case DC, Bosserman L, Litwak DL, Berry WR, Kalman LA, Belt RJ, Saven A. Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study. Clin Lymphoma. 2003 Sep; 4(2):93-8. PMID: 14556680.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  123. Berry W, Dakhil S, Modiano M, Gregurich M, Asmar L. Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer. J Urol. 2002 Dec; 168(6):2439-43. PMID: 12441935.
    Citations: 47     Fields:    Translation:HumansCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Berry's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (445)
Co-Authors (59)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.